Allkem Limited (ASX: AKE, 'Allkem' or the 'Company') is pleased to provide the following update in relation to the proposed merger of equals between Allkem and Livent Corporation ('Livent'), announced to ASX on 10 May 2023 ('Transaction').

Court Approval The Federal Court of Australia has today made orders: that Allkem convene a meeting of Allkem shareholders to consider and vote on the proposed scheme of arrangement between Allkem and its shareholders that forms part of the Transaction ('Scheme'), ('Scheme Meeting') and approving the dispatch to Allkem shareholders of a notice of meeting and explanatory statement in relation to the Scheme ('Scheme Booklet').

Scheme Booklet

The Scheme Booklet will be released to ASX and sent to Allkem shareholders following registration with the Australian Securities and Investments Commission ('ASIC'). It will also be available on Allkem's website at https://www.allkem.co/. The Scheme Booklet will include a copy of the Independent Expert's Report, which has been prepared by Kroll Australia Pty Ltd.

The Scheme Booklet will be dispatched to Allkem Shareholders as follows: Allkem shareholders who have elected to receive hard copies of communicationsfrom Allkem will receive (by post) a physical copy of the Scheme Booklet, along with a personalised proxy form for the Scheme Meeting; Allkem shareholders who have elected to receive electronic communications from Allkem will receive an email containing instructions about how to access and download a copy of the Scheme Booklet, as well as how to lodge their proxy form and/or voting instructions; Allkem shareholders who have not made an election (to either receive electronic or hard copy communications from Allkem) will receive a letter (by post) containing instructions about how to access and download a copy of the Scheme Booklet, along with a personalised proxy form for the Scheme Meeting. Allkem Shareholders should carefully read the Scheme Booklet in its entirety, including the materials accompanying it, before deciding whether to vote in favour of the Scheme.

Scheme Meeting

The Scheme Meeting will be held at The Studio, Level 2, Crown Towers, Crown Perth Convention Centre, Great Eastern Highway, Burswood, Western Australia 6100, on 19 December 2023 commencing at 10:30am (AWST) / 1:30pm (AEDT). Allkem shareholders can also attend the Scheme Meeting virtually, via the online platform at https://meetnow.global/MUHNARQ. Further details of how to access the online platform and participate in the Scheme Meeting online will be contained in the Notice of Scheme Meeting included in the Scheme Booklet, and the Computershare Online Meeting Guide that is included in the Notice of Scheme Meeting.

Investor Relations & Media Enquiries Andrew Barber M: +61 418 783 701 E: Andrew.Barber@allkem.co Phoebe Lee P: +61 7 3064 3600 E: Phoebe.Lee@allkem.co

This announcement has been prepared for publication in Australia and may not be released to U.S. wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction, and neither this announcement or anything attached to this announcement shall form the basis of any contract or commitment. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States except in transactions registered under the U.S. Securities Act of 1933 or exempt from, or not subject to, the registration of the U.S. Securities Act of 1933 and applicable U.S. state securities laws.

(C) 2023 Electronic News Publishing, source ENP Newswire